Analytical Data
-
Gene name
CDH26
- Application
-
Alternative Names
VR20; Cadherin-like protein 26
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IXH8
-
Expression Region
Asp28~His614
-
Molecular Weight
86kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDH26, or Cadherin 26, is a member of the cadherin family, which plays a crucial role in cell adhesion and communication. Its expression has been observed in various tissues, particularly in the epithelial cells of the gastrointestinal tract. Recent studies have suggested that CDH26 may be involved in several pathological conditions, including cancer, where it may influence tumor progression and metastasis. Understanding the structure and function of CDH26 is critical for elucidating its role in cellular processes and disease mechanisms. The production of recombinant CDH26 protein has become an important focus for researchers aiming to investigate its biochemical properties and interactions with other cellular components. Through the generation of this recombinant protein, scientists can conduct functional assays, structural studies, and explore potential therapeutic applications. The study of CDH26 in a recombinant form may provide insights into its involvement in cell signaling pathways and its potential as a biomarker or therapeutic target in diseases such as colorectal cancer. Overall, the research surrounding CDH26 and its recombinant protein aims to advance our understanding of cadherin-related functions in health and disease, paving the way for novel diagnostic and therapeutic strategies.
